Core Insights - The rising COVID-19 positivity rate across multiple regions in China highlights the importance of early detection and intervention for respiratory diseases [1] - JD Health's "medical, testing, diagnosis, and medication" one-stop service is transforming how users manage their health, allowing them to receive comprehensive care without leaving home [3] Group 1: Service Adoption and Growth - The volume of consultations related to fever on JD Internet Hospital increased by 20% week-over-week from May 14 to May 20 [4] - Orders for respiratory pathogen testing through JD's fast testing service doubled during the same period [4] - Orders for flu-related medications on JD's online pharmacy surged by over 80%, with sales of specific COVID-19 treatment drugs increasing by 3.5 times [4] Group 2: User Experience and Future Plans - JD Health's closed-loop service model allows users to consult doctors online, conduct tests at home, receive medications at home, and access nursing services, making it a preferred choice for health issues [6] - Users can seamlessly connect to the entire process of consultation, testing, diagnosis, and medication through the JD app, ensuring quick identification of health issues and precise medication [6] - JD Health plans to continuously optimize its service processes to provide more efficient and diverse healthcare services to the public [6]

Group 1 - The recent COVID-19 outbreak, highlighted by the diagnosis of singer Eason Chan, has led to a significant increase in demand for antiviral medications and online consultations, with antiviral drug sales on JD.com increasing by 700% year-on-year and 75% month-on-month [1] - JD Health's online hospital has reported a 20% week-on-week increase in COVID-19 related consultations, indicating a rising public concern regarding respiratory infections [1] - JD Health provides 24/7 services for patients, allowing them to access professional medical consultations and medication guidance through the JD app [1] Group 2 - JD.com has ensured a sufficient inventory of respiratory pathogen-related medications, including seven preferred antiviral drugs specifically for COVID-19, such as Molnupiravir and Nirmatrelvir/Ritonavir [2] - To alleviate patient burdens, JD Health has reduced prices on certain antiviral medications, including a 20 yuan decrease on a combination pack of Nirmatrelvir and Ritonavir [2] - JD Health has also launched China's first self-developed influenza-specific drug, Isodax, which has shown to significantly shorten the duration of flu symptoms with a single dose [2] Group 3 - Medical professionals recommend that the public maintain hygiene practices, such as regular handwashing and wearing masks, and seek medical attention promptly if experiencing severe symptoms [3] - Special populations, including the elderly and pregnant women, are advised to monitor their blood oxygen levels to prevent dangerous situations due to hypoxia [3]